2,655 Shares in Cigna Group $CI Purchased by Godshalk Welsh Capital Management Inc.

Godshalk Welsh Capital Management Inc. bought a new stake in shares of Cigna Group (NYSE:CI) during the 1st quarter, Holdings Channel.com reports. The institutional investor bought 2,655 shares of the health services provider’s stock, valued at approximately $708,000.

A number of other large investors also recently added to or reduced their stakes in CI. Vanguard Group Inc. boosted its stake in Cigna Group by 1.6% in the 4th quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock worth $7,203,754,000 after purchasing an additional 414,834 shares during the period. State Street Corp raised its position in shares of Cigna Group by 1.8% during the fourth quarter. State Street Corp now owns 12,339,250 shares of the health services provider’s stock valued at $3,396,132,000 after buying an additional 224,122 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in shares of Cigna Group by 8.3% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock worth $3,249,113,000 after buying an additional 903,334 shares in the last quarter. Dodge & Cox lifted its holdings in shares of Cigna Group by 19.7% in the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock worth $3,065,681,000 after buying an additional 1,833,389 shares in the last quarter. Finally, GQG Partners LLC boosted its position in shares of Cigna Group by 14.3% during the fourth quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock worth $2,136,699,000 after acquiring an additional 972,302 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Cigna Group

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the sale, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several research firms recently weighed in on CI. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a research note on Monday, June 1st. Cantor Fitzgerald boosted their price target on shares of Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a research note on Friday, May 1st. Barclays downgraded shares of Cigna Group from an “overweight” rating to an “equal weight” rating and dropped their price objective for the company from $310.00 to $304.00 in a report on Tuesday, May 26th. The Goldman Sachs Group lifted their target price on Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Finally, Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, June 20th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $338.80.

Cigna Group Trading Down 1.8%

CI stock opened at $285.29 on Thursday. The firm has a fifty day moving average price of $286.11 and a 200 day moving average price of $280.66. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47. The firm has a market cap of $75.47 billion, a PE ratio of 12.09, a price-to-earnings-growth ratio of 1.12 and a beta of 0.29. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. During the same quarter in the prior year, the firm earned $6.74 earnings per share. Cigna Group’s revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Sell-side analysts anticipate that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio is currently 26.45%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.